Page 2 - Herlev News Today

The researchers observed arrhythmia within 180 days in 42 and 107 individuals in the medical cannabis and control groups, respectively.

FRIDAY, Jan. 12, 2024 (HealthDay News) -- For patients with chronic pain, medical cannabis use is associated with an increased risk for new-onset arrhythmia, according to a study published online Jan. 11 in the European Heart Journal. Anders Holt, M.D., from Copenhagen University Hospital -- Herlev and Gentofte in Denmark, and colleagues used nationwide Danish

People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, too quickly or irregularly. It includes conditions like atrial fibrillation.

People who take medical cannabis for chronic pain may be at a slightly higher risk of developing an abnormal heart rhythm than those not taking the substan | Cannabis Sciences

Intravenous and intratumoral treatment with TILT-123 was found to be safe and feasible, with no dose-limiting toxicities when given alone or in combination with tumor infiltrating lymphocyte therapy in patients with advanced, metastatic melanoma.

While the field awaits targeted therapies, estimates of absolute 10-year risks can be used to counsel patients, researchers say.

Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.

Rolling one-year VC fund returns fell to -17% in 2022, while VC fundraising is on track to hit a 6-year low by the end of the year.

New research from Copenhagen University Hospital – Rigshospitalet and Herlev and Gentofte Hospital has shed new light on the immune system’s complex struggle against the coronavirus.

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.